Janus Henderson Group PLC Legend Biotech Corp Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,092,732 shares of LEGN stock, worth $69.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,092,732
Previous 2,057,804
1.7%
Holding current value
$69.3 Million
Previous $69.8 Million
6.37%
% of portfolio
0.04%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding LEGN
# of Institutions
237Shares Held
60MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$229 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$198 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$189 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$125 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$98.1 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.54B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...